The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and &q Aug 13, 2026 09:00AM
/C O R R E C T I O N -- The Galien Foundation/ Aug 13, 2026 09:00AM
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032 Jul 1, 2025 09:50AM
Compass Pathways initiates UK component of global phase 3 study of psilocybin treatment in treatment-resistant depression and launches new research center Nov 15, 2023 04:00AM
Numinus to research COMP360 psilocybin therapy in treatment-resistant depression as part of large phase 3 study May 30, 2023 07:00AM


Dec 10, 2021 08:00PM Annual Changes to the Nasdaq Biotechnology Index
Aug 18, 2021 09:00AM Peptilogics and Cerebras Systems Partner on AI Solutions to Advance the Future of Peptide Therapeutics
Jan 19, 2021 07:33AM PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation Targeting Mental Health, Neurological and Pain Disorders